Tsukamoto H, Inui K, Okada S
Department of Pediatrics, Osaka University Medical School.
Nihon Rinsho. 1993 Sep;51(9):2428-34.
The PCR methods for carrier and prenatal diagnosis of Duchenne and Becker muscular dystrophy are described. When a deletion of the dystrophin gene is detected in the proband, the deletion analysis is informative for prenatal diagnosis, and the quantitative PCR analysis of the concerned exons is necessary for carrier diagnosis. When a deletion is not detected, RFLPs analysis should be considered. We analyzed seven polymorphic makers (pERT87-15 combined with digestions with BamHI or XmnI, pERT87-8 combined with digestion with TaqI, and four CA repeat markers at the 5' end and the 3' untranslated regions of the dystrophin gene) by PCR methods. Every woman examined showed a heterozygous finding for at least one of these markers, making it possible to make carrier and prenatal diagnosis. However, it is important to keep in mind that a third of the patients are due to new mutations and that about 10% recombination rate, between the 5' and 3' ends of the dystrophin gene, can exist.
本文描述了用于杜兴氏和贝克氏肌营养不良症携带者及产前诊断的聚合酶链反应(PCR)方法。当在先证者中检测到肌营养不良蛋白基因缺失时,缺失分析对产前诊断有参考价值,而对相关外显子进行定量PCR分析对携带者诊断是必要的。当未检测到缺失时,则应考虑进行限制性片段长度多态性(RFLP)分析。我们通过PCR方法分析了七个多态性标记(pERT87 - 15与BamHI或XmnI酶切结合、pERT87 - 8与TaqI酶切结合,以及肌营养不良蛋白基因5'端和3'非翻译区的四个CA重复标记)。每个接受检测的女性至少在其中一个标记上显示出杂合性结果,从而使得进行携带者及产前诊断成为可能。然而,必须牢记的是,三分之一的患者是由新突变引起的,并且在肌营养不良蛋白基因的5'端和3'端之间可能存在约10%的重组率。